Clinical trials: Left Atrial Appendage Occluder
Non-valvular Atrial Fibrillation (NVAF), High Risk of Stroke
A Prospective, Single-arm Study Evaluating the Endothelialization Effect and Timeline of AnchorMan® Left Atrial Appendage Occluder in Non-valvular Atrial Fibrillation Patients at High Risk of Stroke
This study aims to evaluate the endotheliation efficacy of the AnchorMane® Left Atrial Appendage Occluder in non-valvular atrial fibrillation patients at high stroke risk.
- Trial name
- AnchorMan-NVAF (NCT07396493)
- Testing
- Intra-operative application of LAAC
- Volunteers
- 306 people
- Sponsor
- Shanghai Zhongshan Hospital
Atrial Fibrillation, Stroke
Left-Atrium-Appendage Occluder Register - GErmany
Evaluation of safety and effectiveness of implantable LAA occluder in clinical practice Indication: For which reasons is the indication for implantation of LAA-Occluder put for patients with atrial fibrillation? Safety: How save…
- Trial name
- LAARGE (NCT02230748)
- Where
- 4 sites in Germany
- Volunteers
- 643 people
- Sponsor
- Stiftung Institut fuer Herzinfarktforschung
Atrial Fibrillation, Cardiac Perforation
Complications From Left Atrial Appendage Occluder
The following case reported a rare complication of left atrial appendage perforation complicated by cardiac tamponade during LAAO device deployment and its corresponding surgical management
- Conditions
- Atrial Fibrillation, Cardiac Perforation, Cardiac Tamponade
- Trial name
- NCT05086653
- Testing
- Surgery
- Where
- Taiwan
- Volunteers
- 1 people
- Sponsor
- Kaohsiung Medical University